ATLANTA, Feb. 4 /PRNewswire/ -- Given the intricacies surrounding the Health Information Technology for Economic and
Part of the 2009 American Recovery and Reinvestment Act, the HITECH Act offers incentives to physicians and hospitals who implement electronic medical records (EMR) and starting in 2015, penalties for those who do not.
In 2005 Elekta created STRATEGIQ Services, a consultative services program that helps cancer centers restructure their administrative and clinical processes, identifying new processes that enable customers to perform at their best. Given the government incentives for the HITECH Act, we have expanded our services to help better prepare our customers. Elekta understands the critical needs for our customers to qualify for the incentive payments and avoid costly Medicare penalties.
"Elekta is committed to providing solutions that not only help clinicians deliver superior patient care but add clinical and operational value to their practice," says Jay Hoey President and CEO of Elekta North America. "With STRATEGIQ Services, we can assess where your center is today, determine what changes need to happen and tailor a plan that allows your facility to demonstrate meaningful use."
Elekta will host complimentary webinars for existing customers entitled: STRATEGIQ Services and the HITECH Act February 15, 17 and 18. To register and submit questions, visit supportplus.impac.com.
To learn more about STRATEGIQ Services and the HITECH Act, visit www.elekta.com/strategiq or contact us at email@example.com.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.
Subscribe to our Free Newsletters!
Tourette syndrome (TS) is a neurological disorder wherein the affected person makes repetitive and ...
Some drugs or therapeutic agents cause undesirable reactions in lungs, known as drug-induced ...
Sleep disorders are collectively known as ''Somnipathy.'' There are over 70 different medically ...View All